|
2025 Conference Publication Machine Learning-Generated Longitudinal Synthetic International Data in Multiple SclerosisIqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Shaygannejad, Vahid, Karabudak, Rana, Patti, Francesco, Zamzam, Dina, Alroughani, Raed, Etemadifar, Masoud, Boz, Cavit, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Amato, Maria Pia, Grand'Maison, Francois, Kermode, Allan, Pedrini, Marzena, Carroll, William, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin ... Kalincik, Tomas (2025). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosisKalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J. William L., Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Scott, Jeannette Lechner, Van Wijmeersch, Bart, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John (2025). Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry AnalysisButzkueven, Helmut, van der Walt, Anneke, Spelman, Tim, Kermode, Allan, Pedrini, Marzena, Carroll, William, Scott, Jeannette Lechner, John, Nevin A., Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Buzzard, Katherine, Nelson, Morag, Schmitt, Birte and Martel, Kate (2025). Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Causal effects of multiple sclerosis therapies in left-truncated registry dataHaile, Dagmawi, Diouf, Ibrahima, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva, Patti, Francesco, Izquierdo Ayuso, Guillermo, Eichau, Sara, Alroughani, Raed, Lugaresi, Alessandra, Tomassini, Valentina, Boz, Cavit, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Buzzard, Katherine, Skibina, Olga, Yamout, Bassem I., Terzi, Murat, Khoury, Samia, Grammond, Pierre, Scott, Jeannette Lechner, Blanco, Yolanda, Shaygannejad, Vahid, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Weinstock-Guttman, Bianca, Prevost, Julie ... Kalincik, Tomas (2025). Causal effects of multiple sclerosis therapies in left-truncated registry data. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National ScalesSreenivasan, Akshai Parakkal, Sharmin, Sifat, Noui, Yassine, Ozakbas, Serkan, Etemadifar, Masoud, Alroughani, Raed, Shaygannejad, Vahid, Patti, Francesco, Boz, Cavit, Brown, J. William L., Coles, Alasdair, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Yamout, Bassem I., Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Roos, Izanne, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Habek, Mario, Zakaria, Magd Fouad, Amato, Maria Pia, Prevost, Julie, Gerlach, O. ... Kultima, Kim (2025). From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National Scales. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Cladribine as an exit strategy in people with MS over the age of 50Roos, Izanne, Sharmin, Sifat, Mueller, Jannis, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Libertinova, Jana, Mares, Miroslav, Grammond, Pierre, Prevost, Julie, Rous, Zuzana, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Hradilek, Pavel, van der Walt, Anneke, Butzkueven, Helmut, Boz, Cavit, Patti, Francesco, Barnett, Michael, Izquierdo Ayuso, Guillermo, Eichau, Sara, Blanco, Yolanda, Meca-Lallana, Jose E., Foschi, Matteo, Surcinelli, Andrea ... Kalincik, Tomas (2025). Cladribine as an exit strategy in people with MS over the age of 50. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple SclerosisGomez Figueroa, Enrique, Orozco Puga, Patricia, Corona Vazquez, Cynthia, Moreno Bernardino, Carlos Javier, De la Mora Landin, Graciela, Jimenez-Ruiz, Amado, Garcia Estrada, Christian Alan, Zertuche-Ortuno, Lizeth, Saldivar Davila, Sergio, Rivas, Roberto Rodriguez, Bazan, Anna Lisette, Rivera, Jose Flores, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Spitaleri, Daniele, McCombe, Pamela, Sanchez Menoyo, Jose Luis ... Ruiz-Sandoval, Jose Luis (2025). Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Bayesian network to generate representative longitudinal data in multiple sclerosisQiang, Zhe, Iqbal, Hassam, Sharmin, Sifat, Ozakbas, Serkan, Zakaria, Magd Fouad, Etemadifar, Masoud, Alroughani, Raed, Boz, Cavit, Karabudak, Rana, Shaygannejad, Vahid, Habek, Mario, Terzi, Murat, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Kermode, Allan, Pedrini, Marzena, Carroll, William, Horakova, Dana, Havrdova, Eva, Soysal, Aysun, Altintas, Ayse, Turkoglu, Recai, Gouider, Riadh, Mrabet, Saloua, Ayuso, Guillermo Izquierdo ... Kalincik, Tomas (2025). Bayesian network to generate representative longitudinal data in multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort studyRoos, Izanne, Sharmin, Sifat, Horakova, Dana, Ozakbas, Serkan, Libertinova, Jana, Boz, Cavit, Alroughani, Raed, Barnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Rous, Zuzana, Mares, Miroslav, Buzzard, Katherine, Peterka, Marek, Scott, Jeannette Lechner, Foschi, Matteo, Surcinelli, Andrea, Hradilek, Pavel, Prevost, Julie, Brown, William, Eichau, Sara, Blanco, Yolanda, Terzi, Murat, Meca-Lallana, Jose E., Laureys, Guy, Grammond, Pierre, John, Nevin A., Soysal, Aysun, Ampapa, Radek ... Kalincik, Tomas (2025). Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?Hradilek, Pavel, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana, Peterka, Marek, Stourac, Pavel, Mares, Jan, Alroughani, Raed, Ozakbas, Serkan, Karabudak, Rana, Boz, Cavit, Yammout, Bassem, Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Scott, Jeannette Lechner, McGuigan, Christopher, Prat, Alexandre ... Fistravec, Gregor (2025). Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication The risk of secondary progressive multiple sclerosis is geographically determined but modifiableSharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Kermode, Allan, Butler, Ernest, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Taylor, Bruce, Slee, Mark, Macdonell, Richard, Garber, Justin, Shaw, Cameron, Shuey, Neil, Massey, Jennifer, Hardy, Todd, Parratt, John and Kalincik, Tomas (2024). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosisMaltby, Vicki E., Xavier, Alexandre, Monif, Mastura, Min, Myintzu, Fabis-Pedrini, Marzena J., Buzzard, Katherine, Kalincik, Tomas, Kermode, Allan G., Taylor, Bruce, Hodgkinson, Suzanne, McCombe, Pamela, Osborne, Meaghan, Butzkueven, Helmut, Barnett, Michael, Lea, Rodney A. and Lechner-Scott, Jeannette (2024). DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaborationLaing, N., Kennerson, M., Lamont, P., Vucic, S., Davis, M., Bryson-Richardson, R., Ravenscroft, G., Perez-Siles, G., Ghaoui, R., Narayanan, R., McCombe, P., Deveson, I., Bryen, S., Grosz, B., Johari, M., Rick, A., Folland, C., Scriba, C., Parmar, J. and Ellis, M. (2024). Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration. 29th International Congress of the World-Muscle-Society (WMS), Prague, Czech Republic, 8-12 October 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.nmd.2024.07.328 |
|
2024 Conference Publication Real-world experience with Cladribine (Mavenclad) in the MSBase registryButzkueven, Helmut, Spelman, Tim, Van der Walt, Anneke, Hodgkinson, Suzanne, Ozakbas, Serkan, Alroughani, Raed, Kalincik, Tomas, Eichau, Sara, Boz, Cavit, Buzzard, Katherine, Habek, Mario, John, Nevin, Kermode, Allan G., Foschi, Matteo, McCombe, Pamela, Gerlach, Oliver, Prevost, Julie, Meca-Lallana, Jose E., Lapointe, Emmanuelle and Jarvinen, Elina (2024). Real-world experience with Cladribine (Mavenclad) in the MSBase registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase RegistryBarnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Hodgkinson, Suzanne, McCombe, Pamela, Macdonell, Richard, Slee, Mark, Migocki, Margaret, Martel, Kate and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase Registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase registryMigocki, Margaret, Walt, Anneke Van der, Butzkueven, Helmut, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase registry. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.127 |
|
2024 Conference Publication Utilisation of high efficacy therapy for managing multiple sclerosis in AustraliaMcCombe, Pamela, Butzkueven, Helmut, Samjoo, Imtiaz, Barnett, Michael, Broadley, Simon, Walt, Anneke Van der, Merschhemke, Martin, Adlard, Nicholas, Burke, Naomi, Riley, Nicholas and Walker, Rob (2024). Utilisation of high efficacy therapy for managing multiple sclerosis in Australia. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.23 |
|
2024 Conference Publication Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple SclerosisNelson, Morag, Butzkueven, Helmut, Van der Walt, Anneke, Broadley, Simon, Riley, Nicholas, Adlard, Nicholas, Merschhemke, Martin, Stoneman, Dee, McCombe, Pamela, Barnett, Michael, Walker, Rob, Samjoo, Imtiaz, Haltner, Anja and Drudge, Chris (2024). Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple Sclerosis. 16th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis, Bangkok, Thailand, 30 October - 2 November 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Effects of Cladribine on Vaccine Recall Responses in MSGreer, J. M., Csurhes, P. A. and McCombe, P. (2024). Effects of Cladribine on Vaccine Recall Responses in MS. Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Forum (ACTRIMS), West Palm Beach Fl, Feb 29-Mar 02, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2023 Conference Publication Novel real world evidence from MSGo, a digital support program for secondary progressive multiple sclerosis patients in Australia using SiponimodHardy, Todd, Aouad, Patrick, Barnett, Michael, Blum, Stefan, Broadley, Simon, Carroll, William, Crimmins, Denis, Griffiths, Dayna, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lee, Andrew, Malhotra, Ram, McCombe, Pamela, Parratt, John, Plummer, Christopher, Van der Walt, Anneke, Martel, Kate and Walker, Rob (2023). Novel real world evidence from MSGo, a digital support program for secondary progressive multiple sclerosis patients in Australia using Siponimod. PACTRIMS 2022: 12th Pan-Asian Committee for Treatment and Research in Multiple Sclerosis, Singapore, Singapore, 24-26 November 2022. London, United Kingdom: Sage Publications. |
